These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 16336741

  • 1. Molecular pathogenesis of rheumatic fever and rheumatic heart disease.
    Guilherme L, Faé K, Oshiro SE, Kalil J.
    Expert Rev Mol Med; 2005 Dec 08; 7(28):1-15. PubMed ID: 16336741
    [Abstract] [Full Text] [Related]

  • 2. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis.
    Guilherme L, Ramasawmy R, Kalil J.
    Scand J Immunol; 2007 Dec 08; 66(2-3):199-207. PubMed ID: 17635797
    [Abstract] [Full Text] [Related]

  • 3. Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions.
    Guilherme L, Faé KC, Oshiro SE, Tanaka AC, Pomerantzeff PM, Kalil J.
    Ann N Y Acad Sci; 2005 Jun 08; 1051():132-40. PubMed ID: 16126952
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heart-directed autoimmunity: the case of rheumatic fever.
    Guilherme L, Cunha-Neto E, Tanaka AC, Dulphy N, Toubert A, Kalil J.
    J Autoimmun; 2001 May 08; 16(3):363-7. PubMed ID: 11334505
    [Abstract] [Full Text] [Related]

  • 7. PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients.
    Faé KC, Diefenbach da Silva D, Bilate AM, Tanaka AC, Pomerantzeff PM, Kiss MH, Silva CA, Cunha-Neto E, Kalil J, Guilherme L.
    J Autoimmun; 2008 Sep 08; 31(2):136-41. PubMed ID: 18541406
    [Abstract] [Full Text] [Related]

  • 8. How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease.
    Faé KC, Oshiro SE, Toubert A, Charron D, Kalil J, Guilherme L.
    J Autoimmun; 2005 Mar 08; 24(2):101-9. PubMed ID: 15829402
    [Abstract] [Full Text] [Related]

  • 9. Towards a vaccine against rheumatic fever.
    Guilherme L, Faé KC, Higa F, Chaves L, Oshiro SE, Freschi de Barros S, Puschel C, Juliano MA, Tanaka AC, Spina G, Kalil J.
    Clin Dev Immunol; 2006 Mar 08; 13(2-4):125-32. PubMed ID: 17162355
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rheumatic fever: from innate to acquired immune response.
    Guilherme L, Kalil J.
    Ann N Y Acad Sci; 2007 Jun 08; 1107():426-33. PubMed ID: 17804571
    [Abstract] [Full Text] [Related]

  • 12. Rheumatic Heart Disease: Pathogenesis and Vaccine.
    Guilherme L, de Barros SF, Kohler KF, Santos SR, Ferreira FM, Silva WR, Alencar R, Postol E, Kalil J.
    Curr Protein Pept Sci; 2018 Jun 08; 19(9):900-908. PubMed ID: 28745221
    [Abstract] [Full Text] [Related]

  • 13. Progress in M-protein-based subunit vaccines to prevent rheumatic fever and rheumatic heart disease.
    Olive C.
    Curr Opin Mol Ther; 2007 Feb 08; 9(1):25-34. PubMed ID: 17330399
    [Abstract] [Full Text] [Related]

  • 14. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease.
    Guilherme L, Kalil J, Cunningham M.
    Autoimmunity; 2006 Feb 08; 39(1):31-9. PubMed ID: 16455580
    [Abstract] [Full Text] [Related]

  • 15. T cell response in rheumatic fever: crossreactivity between streptococcal M protein peptides and heart tissue proteins.
    Guilherme L, Faé KC, Oshiro SE, Tanaka AC, Pomerantzeff PM, Kalil J.
    Curr Protein Pept Sci; 2007 Feb 08; 8(1):39-44. PubMed ID: 17305559
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-10: Role in increasing susceptibility and pathogenesis of rheumatic fever/rheumatic heart disease.
    Sharma N, Toor D.
    Cytokine; 2017 Feb 08; 90():169-176. PubMed ID: 27918954
    [Abstract] [Full Text] [Related]

  • 17. An immunological perspective on rheumatic heart disease pathogenesis: more questions than answers.
    Bright PD, Mayosi BM, Martin WJ.
    Heart; 2016 Oct 01; 102(19):1527-32. PubMed ID: 27260192
    [Abstract] [Full Text] [Related]

  • 18. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease.
    Thakur A, Singhal S, Prakash K.
    J Med Microbiol; 1996 Dec 01; 45(6):483-9. PubMed ID: 8958254
    [Abstract] [Full Text] [Related]

  • 19. Rheumatic Heart Disease: Molecules Involved in Valve Tissue Inflammation Leading to the Autoimmune Process and Anti-S. pyogenes Vaccine.
    Guilherme L, Kalil J.
    Front Immunol; 2013 Oct 30; 4():352. PubMed ID: 24198818
    [Abstract] [Full Text] [Related]

  • 20. Distribution of cells bearing "rheumatic" antigens in peripheral blood of patients with rheumatic fever/rheumatic heart disease.
    Regelmann WE, Talbot R, Cairns L, Martin D, Miller LC, Zabriskie JB, Braun D, Gray ED.
    J Rheumatol; 1989 Jul 30; 16(7):931-5. PubMed ID: 2475627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.